Cronin Scott J, El-Kashlan Hussam K, Telian Steven A
Department of Otolaryngology, University of Michigan, Ann Arbor, Michigan, U.S.A.
Otol Neurotol. 2014 Sep;35(8):e215-21. doi: 10.1097/MAO.0000000000000481.
The objective of this study is to describe the presentation and management of a rare site of cholesteatoma recurrence at the bony-cartilaginous junction after intact canal wall (ICW) mastoidectomy.
Retrospective case series
Tertiary referral center
Patients with cholesteatoma formation arising from the bony-cartilaginous (BC) junction of the external auditory canal (EAC) requiring surgical intervention were retrospectively identified across a 5-year period.
INTERVENTION(S): All patients were treated surgically to eradicate the disease and reconstruct the bony defect when possible.
MAIN OUTCOME MEASURE(S): This observational study details the presentation, risk factors, and management of a rare site of cholesteatoma recurrence after ICW mastoidectomy.
After ICW mastoidectomy, eight patients were identified with fistulae in the lateral EAC near the BC junction. Seven patients had associated iatrogenic cholesteatomas arising at this site, and one patient had a dry fistula with bony stenosis of the EAC. All patients had a history of chronic otitis media and previous surgery. Patients averaged 9 years between surgery and recidivism. Reconstruction of the bony defect was completed using hydroxyapatite reconstruction plates in four patients with 75% success, soft wall reconstruction in two patients using temporalis muscle, and canal wall down mastoidectomy in two patients who had extensive disease and exposed dura. No recurrent disease was evident during an average follow-up of 16 months. EAC reconstruction was successful in 83% of cases.
This case series reports a novel pattern of iatrogenic cholesteatoma formation near the BC junction of the EAC that can occur years after ICW mastoidectomy. In properly selected cases, this condition can be managed with revision ICW mastoidectomy and reconstruction.
本研究的目的是描述在完整外耳道壁(ICW)乳突切除术后,胆脂瘤在骨软骨交界处这一罕见复发部位的表现及处理。
回顾性病例系列
三级转诊中心
回顾性确定了在5年期间,因外耳道(EAC)骨软骨(BC)交界处形成胆脂瘤而需要手术干预的患者。
所有患者均接受手术治疗以根除疾病,并尽可能重建骨缺损。
本观察性研究详细描述了ICW乳突切除术后胆脂瘤罕见复发部位的表现、危险因素及处理。
ICW乳突切除术后,8例患者被发现外耳道外侧靠近BC交界处存在瘘管。7例患者在此部位伴有医源性胆脂瘤形成,1例患者有干性瘘管伴外耳道骨狭窄。所有患者均有慢性中耳炎病史及既往手术史。患者手术至复发的平均间隔时间为9年。4例患者使用羟基磷灰石重建板完成骨缺损重建且成功率为75%,2例患者使用颞肌进行软壁重建,2例病变广泛且硬脑膜暴露的患者接受了开放式乳突切除术。平均随访16个月期间未见疾病复发。外耳道重建成功率为83%。
本病例系列报告了一种医源性胆脂瘤在EAC的BC交界处附近形成的新模式,这种情况可在ICW乳突切除术后数年发生。在适当选择的病例中,这种情况可通过ICW乳突切除术翻修及重建进行处理。